Search

You searched for "Wales"

2859 results found

New SpaMedica site opens in Bexhill-on-Sea

2 June 2023 | spamedica, infrastructure, Cataract surgery
SpaMedica, which specialises in NHS cataract surgery and YAG capsulotomy, will help to significantly reduce waiting times for East Sussex patients.
Neuro-Ophthalmology journal cover image

Rare presentation of giant cell arteritis in Chinese subjects

1 September 2023 | | EYE - Neuro-ophthalmology | non-arteritic anterior ischaemic optic neuropathy, Chinese, central retinal artery occlusion, Giant cell arteritis, ocular ischaemic syndrome, posterior ischaemic optic neuropathy
Only a few case reports of biopsy-proven GCA (BpGCA)-associated vision loss in Chinese subjects have been published. This paper presents three elderly Chinese subjects with BpGCA who presented with vision loss. A search of the literature was also conducted to...
Eye journal cover image.

The expanding spectrum of idiopathic intracranial hypertension

2 February 2024 | | EYE - Neuro-ophthalmology
This is a review article from a tertiary centre in Atlanta, US. With rising obesity rates and increasing access for MRI scans there has been a large increase in patients requiring an urgent papilloedema check with incidental findings on MRI...

XXII SARCS (State of the Art Refractive Cataract Surgery) Symposium 2024

14 June 2024
by Andrew Bourne, BSc, MCOptom, DipTp(IP), Dip Glauc, Principal Optometrist, Hull & East Yorkshire Eye Hospital, UK. Once again, Milind Pande welcomed over 220 ophthalmologists and allied professionals to his annual symposium, this year held once again at the University...

Good News from Switzerland: A History of Retinal Reattachment Surgery

1 December 2014 | | EYE - Vitreo-Retinal
In one concise volume the reader learns of the recent rapid evolution in vitreoretinal (VR) surgery. The pioneering innovators were often remarkable personalities and this book helps to bring them to life. Prior to 1929 victims of retinal detachment were...

The results of the last survey Oct24

3 October 2024 | | EYE - Glaucoma
*Please be aware that this data does not form part of a peer reviewed research study. The information therein should not be relied upon for clinical purposes but instead used as a guide for clinical practice and reflection. The sample...

How to be ‘appy’ on call: a brief guide to mobile phone applications for the on-call ophthalmologist

1 December 2022 | | EYE - General
One of the unexpected outcomes of the COVID-19 pandemic has been an increased reliance and integration of computer technology within hospital medicine. The need for stricter infection control policies during and after lockdown has seen a boom in technology utilisation....

Unilateral central scotoma following dengue fever

12 October 2023 | | EYE - Neuro-ophthalmology
Case report A 16-year-old Caucasian male was referred to the eye casualty at Nottingham University Hospitals NHS Trust by the infectious diseases unit in September 2013. He gave a history of photophobia, pain on eye movements and central blurred vision...

CALA Homes donates white boards to help pupils at Royal Blind School

4 May 2023 | Sight Scotland, Royal Blind School, vision impairment, Children
Homebuilder Cala Homes (East) has donated £3,130 to Sight Scotland for the purchase of two white boards to aid teaching at the Royal Blind School in Edinburgh.

Moorfields Eductation: ocular oncology for the non-ocular oncologist: what you need to know for clinical practice

9 May 2025
This brand new course is aimed at ophthalmologists, trainees, optometrists and medical retina specialists and will cover the following topics: How to assess and diagnose ocular tumoursHow to refer patients to an ocular oncology centreUse of the MOLES score for...

Corporate M&A pace gathers momentum

1 October 2019 | | EYE - General
Intensifying franchise competition, maturing product development pipelines and looming loss of exclusivity spur renewed merger and acquisition (M&A) activity in the ophthalmics sector. Rod McNeil reviews recent deals and related strategic developments. AbbVie to acquire Allergan in $63 billion mega-combination,...

COVID-19: Pete’s Bogus Journey

6 April 2021 | | EYE - General
The author shares his personal experience of contracting coronavirus. I managed to body swerve COVID-19 for nine months. The Pfizer vaccine was being rolled out in my trust. I had my first inoculation booked in three weeks. I had survived...